Blutruve manufactures biotechnology materials and molecular biology reagents specifically designed for research applications in the life sciences. The startup addresses the need for high-quality, reliable reagents that enhance experimental accuracy and reproducibility in scientific studies.
Funding
$7.6K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Life science research relies on specialized biotechnology materials and molecular biology reagents. Inconsistent quality and reliability of these reagents can compromise experimental accuracy and reproducibility, leading to flawed research outcomes.
Solution
Blutruve manufactures and supplies high-quality biotechnology materials and molecular biology reagents tailored for life science research applications. By focusing on stringent quality control and optimized production processes, Blutruve ensures that its reagents deliver consistent performance and reliable results. This enables researchers to enhance the accuracy and reproducibility of their experiments, ultimately accelerating scientific discovery.
Target Audience
Blutruve's primary customers are academic research laboratories, pharmaceutical companies, and biotechnology firms conducting research in molecular biology, genomics, and proteomics.
Features
- Molecular biology reagents optimized for PCR, qPCR, and next-generation sequencing workflows
- Biotechnology materials including buffers, enzymes, and cell culture media
- Stringent quality control testing to ensure lot-to-lot consistency
- Custom reagent formulation and packaging services available